Cancer News and Research

Latest Cancer News and Research

New cellular pathway that operates to restrict inflammation and immunity

Jonsson Cancer Center have discovered a novel anti-inflammatory cell signaling pathway that may serve as a vital Yin-Yang mechanism to maintain the delicate balance of immune response.

16 Jun 2007

Tumor vessels identified by unique molecular markers

Results from a new study have made it easier for scientists to distinguish between growing blood vessels in healthy tissues and those that are associated with tumors.

16 Jun 2007

The big donor shortage

Associate Professor Catherine Waldby of the University of Sydney looks at the fraught and often frightening world of organ donation in an opinion piece.

16 Jun 2007

The unexpected connection of two gene regulation mechanisms points to new ways for the fight against leukemia

When the activity of individual genes it is longer required, there are two main mechanisms responsible for the “switching off”, mainly DNA methylation and the Polycomb protein complex. Sometimes, these mechanisms lose their efficiency and some of the genes that should be "switched off" remain active.

16 Jun 2007

Folic acid supplements do not reduce risk of precancerous colon tumors

Taking folic acid supplements does not reduce the risk of developing precancerous tumors in the colon and may even increase the risk, a new study has found.

16 Jun 2007

Early life sun exposure linked to melanomas with BRAF gene mutations

Skin cancers often contain different gene mutations, but just how these mutations contribute to the cause of melanomas has been a mystery.

16 Jun 2007

Newer breast cancer drug may protect heart

By uncovering how one breast cancer drug protects the heart and another does not, Duke University Medical Center researchers believe they may have opened up a new way to screen drugs for possible heart-related side effects and to develop new drugs.

16 Jun 2007

Type of insurance coverage linked to more advanced cancers

Two new studies find the uninsured and people with certain types of public health insurance are more likely to be diagnosed with more advanced cancer compared to those with private insurance.

16 Jun 2007

Sensitivity to diverse range of chemotherapeutic drugs linked to common pathway

Using a functional genomic screen, scientists have defined elements that impact the responsiveness of cancer cells to drugs commonly used as anticancer therapeutics.

15 Jun 2007

Affluent society faces greater risks for skin cancer

Skin cancer levels have shown a significant increase in Northern Ireland since the early 1990s and are more likely to affect men, older people and those living in more affluent areas, according to a study just published in the June issue of British Journal of Dermatology.

15 Jun 2007

Researchers shed light on shrinking of chromosomes

A human cell contains an enormous 1.8 metres of DNA partitioned into 46 chromosomes.

15 Jun 2007

Researchers find new mechanism of action of the anti-cancer drug sorafenib

Virginia Commonwealth University Massey Cancer Center researchers have uncovered a new mechanism of action of the anti-cancer drug sorafenib, which could stimulate the development of novel regimens in which it is combined with other molecularly targeted agents for patients with blood cancers and solid tumors.

15 Jun 2007

Study shows pre-op red blood cell levels affect post-op outcomes

Men over 65 with even slightly abnormal red blood cell counts either too low or too high are at greater risk of post-operative death or car-diac events following a major non-cardiac surgery, according to a new study by researchers at the Providence Veterans Affairs Medical Center and The Warren Alpert Medical School of Brown University.

15 Jun 2007

In vivo imaging of siRNA delivery and silencing in tumors

Using magnetic nanoparticles labeled with dye molecules, a team of investigators at the Massachusetts General Hospital has developed a delivery vehicle capable of transporting antitumor small interfering RNA (siRNA) molecules into cells.

14 Jun 2007

Aptamer-targeted nanoparticles collect and detect cancer cells

Using magnetic and fluorescent nanoparticles capable of binding tightly to molecules found only on the surface of cancer cells, a team of investigators at the University of Florida has developed a method for collecting and detecting multiple cancer cells from biological samples.

14 Jun 2007

Nanosized bioceramic particles could function as efficient gene delivery vehicles with target specificity for the spleen

A detailed comparison of different types of ceramic nanoparticles has found that those made of silica can efficiently transport therapeutic genes to the spleen and trigger a potent immune response capable of attacking tumors.

14 Jun 2007

Quantum dots outline brain tumors for surgical removal

Although surgical removal of a tumor can be the most effective way of treating brain cancer, neurosurgeons are often faced with the dilemma of determining the exact border between a tumor and the healthy tissue that surrounds it.

14 Jun 2007

Nanoparticle-enabled peptide delivery triggers tumor regression

Cells possess a variety of ways of dealing with mutations that can cause them to grow uncontrollably and eventually form a tumor. The tumor suppressor gene p53 plays a critical role in these cancer prevention processes, largely by triggering a form a cell death known as apoptosis.

14 Jun 2007

Nanoprobes with near-infrared persistent luminescence for in vivo imaging

In a new take on use of luminescent nanoparticles as cancer imaging probes, a team of investigators from several research institutes in Paris, France, has developed new metal-containing nanoparticles that emit light for several hours after they are initially excited.

14 Jun 2007

Interfacing silicon nanowires with mammalian cells

A research team at the University of California, Berkeley, has achieved a significant step toward one of the futuristic goals of nanomedicine and nanobiology-developing technology for "wiring" together individual cells.

14 Jun 2007